Kewaunee Q1 Earnings Slide Amid Global Project Delays

Kewaunee Scientific Corporation posted a decline in first-quarter fiscal 2027 earnings, with sales falling to $66.3 million from $71.1 million a year earlier. Net earnings attributable to the company dropped to $1.7 million from $3.1 million in the prior-year period, while earnings per share declined to 58 cents from $1.04. The company’s overall pretax earnings decreased by 34.7% to $2.6 million, reflecting broader headwinds in project execution and demand timing.

Despite the top-line contraction, the International segment demonstrated improved profitability through a shift toward higher-margin work. International net earnings rose 23.5% to $794,000, and segment EBITDA increased 13.9% to $1.2 million. This performance contrasted with the Lab Products Group, which saw sales decrease 6.4% to $50.9 million and net earnings fall to $3.9 million from $4.7 million in the same quarter last year.

International Segment Drives Margin Gains

The International division recorded sales of $15.5 million, down 7.8% from $16.8 million in the comparable period. However, the segment's financial health improved due to a more favorable mix of projects with higher margins. This operational shift allowed the company to boost net earnings significantly despite the lower revenue base, indicating a strategic focus on project quality over volume in specific geographic markets.

In contrast, the Lab Products Group, the company's largest revenue generator, faced pressure from reduced demand. Sales in this segment dropped to $50.9 million from $54.4 million, leading to a decrease in segment EBITDA from $7.6 million to $6.6 million. The decline in both revenue and profitability within this core business unit contributed heavily to the overall earnings reduction reported for the quarter.

Backlog and Balance Sheet Position

As of July 31, 2026, Kewaunee’s backlog stood at $169 million, up from $165.9 million at the end of the previous fiscal year but down from $205 million a year earlier. Total cash on hand decreased to $10.3 million from $11.6 million at fiscal year-end, while working capital declined to $56.7 million from $66.7 million in the prior year. These figures reflect a tighter liquidity position compared to the previous annual period.

The company’s debt structure saw modest adjustments during the quarter. Short-term debt increased to $6.5 million from $5.9 million, while long-term debt decreased to $39.4 million from $40.9 million. Excluding sale-leaseback financing obligations, long-term debt fell to $13.8 million. The debt-to-equity ratio improved slightly to 0.59-to-1 from 0.61-to-1, indicating a marginal strengthening of the balance sheet leverage profile.

Management Cites Geopolitical Uncertainty

President and CEO Thomas D. Hull III stated that quoting activity remained strong across Kewaunee’s markets, supporting confidence in underlying demand. However, he noted that project award and release timelines have extended due to geopolitical and economic uncertainty. Management emphasized that customer activity remains healthy and highlighted a continued focus on service and operational improvements as quoting activity converts into project awards and releases.

The data from GN markets/earnings (en-US) underscores a period of transition for Kewaunee, where improved international margins are offset by domestic sales declines and extended project cycles. The company’s strategy currently prioritizes maintaining high-margin project flows while navigating prolonged decision-making processes from customers amid global instability.